Cite
MLA Citation
David Straus et al.. “Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy.” Leukemia & lymphoma, vol. 61, no. 12, 2020, pp. 2931–2938. http://access.bl.uk/ark:/81055/vdc_100114890574.0x00002b